Advertisement

Prevention and management of eclampsia

  • F. Paruk
  • S. Bhagwanjee
Conference paper

Abstract

Eclampsia is a pregnancy-specific multisystem disorder associated with substantial fetomaternal morbidity and mortality [1–6]. The incidence of eclampsia is variable, but is generally low in well-resourced regions compared with resource-deficient countries. However, once eclampsia ensues the potential for both morbidity (immediate and long term) and mortality is cause for equal concern. In the context of its elusive aetiology, the prevention and management of this multiorgan disease challenge even the most experienced of clinicians. This paper focuses on the definition of pre-eclampsia/eclampsia, the suggested pathophysiology of the disease, current potential preventative strategies and specific issues of concern in the management of the critically ill eclamptic patient.

Keywords

Systemic Inflammatory Response Syndrome Cerebral Perfusion Pressure Glasgow Coma Score Magnesium Sulphate Hypertensive Encephalopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moodley J, Naicker RS, Mankowitz E (1983) Eclampsia — a method of management. S Afr Med J 63: 530PubMedGoogle Scholar
  2. 2.
    Lewis G (ed) (2001) Why mothers die 1997–1999. The fifth report on the confidential enquiries into maternal deaths in the United Kingdom. RCOG Press, LondonGoogle Scholar
  3. 3.
    Buga GA, Lumu SB (1999) Hypertensive disorders of pregnancy at Umtata General Hospital: perinatal and maternal outcomes. East Afr Med J 76: 217–222PubMedGoogle Scholar
  4. 4.
    Mwinyoglee J, Amoko DH, Simelela N, Marivate M (1996) Eclampsia at Garankuwa Hospital. S Afr Med J 86: 1536–1539PubMedGoogle Scholar
  5. 5.
    Paruk F, Moodley J (2003) Eclampsia: a prospective audit of 112 patients admitted to King Edward VIII Hospital Obstetric High Care Unit (in press)Google Scholar
  6. 6.
    Bhagwanjee S, Paruk F, Muckart DJJ, Moodley J (2000) Morbidity and mortality in critically ill eclamptic patients and the efficacy of APACHE II, the organ failure score and GCS in outcome prediction. Crit Care Med 8: 120–124CrossRefGoogle Scholar
  7. 7.
    Higgins JR, de Swiet M (2002) Blood pressure measurement and classification in pregnancy. Lancet 357: 131–135CrossRefGoogle Scholar
  8. 8.
    Friedman SA, Taylor RN, Roberts JM (1991) Pathophysiology of pre eclampsia. Clin Perinat 18: 661–682Google Scholar
  9. 9.
    Roberts JM (2000) Pre eclampsia: what we know and what we do not know. Semin Perinat 24: 24–28CrossRefGoogle Scholar
  10. 10.
    Redman CW, Sargent IL (2003) Pre-eclampsia, the placenta and the maternal systemic inflammatory response — a review. Placenta 24: S21–27PubMedCrossRefGoogle Scholar
  11. 11.
    Sargent IL, Germain SJ, Sacks GP et al (2003) Trophoblast deportation and the naternal inflammatory response in pre-eclampsia. J Reprod Immunol 59: 153–160PubMedCrossRefGoogle Scholar
  12. 12.
    Norwitz ER, Robinson JN, Repke JT (1999) Prevention of pre-eclampsia: is it possible? Clin Obstet Gynaecol 42: 436–454CrossRefGoogle Scholar
  13. 13.
    Duley I, Henderson-Smart D, Knight M et al (2001) Antiplatelet drugs for prevention of pre eclampsia: systematic review. BMJ 322: 329–333PubMedCrossRefGoogle Scholar
  14. 14.
    Hofmeyr JG, Roodt A, Atallah AN, Duley L (2003) Calcium supplementation to prevent pre eclampsia — a systematic review. S Afr Med J 93: 224–228PubMedGoogle Scholar
  15. 15.
    Olsen S, Secher NJ, Tabor A et al (2000) Randomised clinical trials of fish oil supplementation in high risk pregnancies. Br J Obstet Gynaecol 107: 382–395Google Scholar
  16. 16.
    Leitch CR, Cameron AD, Walker JJ (1998) The changing pattern of eclampsia over a 60 year period. Br J Obstet Gynaecol 104: 917–922Google Scholar
  17. 17.
    The Magpie Trial Collaborative Group (2002) Do women with pre eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 359: 1877–1890CrossRefGoogle Scholar
  18. 18.
    South African Magpie Trial Collaborative Group (2003) The Magpie study-clinical implications for poor countries. S Afr Med J 93: 264–265Google Scholar
  19. 19.
    Belforte MA, Anthony J, Saade GR et al (2003) A comparison of magnesium sulphate and nimodipine for the prevention of eclampsia. NEJM 348: 304–311CrossRefGoogle Scholar
  20. 20.
    Belforte MA, Varne MW, Dizon-Townson DS et al (2002) Cerebral perfusion pressure and not cerebral blood flow, may be the critical determinant of intracranial injury in pre eclampsia: a new hypothesis. Am J Obstet Gynecol 187: 626–634CrossRefGoogle Scholar
  21. 21.
    Belforte MA, Saade GR, Yared M et al (1999) change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulphate in patients with pre eclampsia. Am J Obstet Gynecol 181: 402–407CrossRefGoogle Scholar
  22. 22.
    Paruk F, Moodley J (2000) Treatment of severe pre eclampsia/eclampsia syndrome. In: Studd J (ed) Progress in Obstetrics and Gynecology. 14: 103–119Google Scholar
  23. 23.
    Paruk F, Moodley J (2001) Untoward effects of rapid acting antihypertensive hypertensive agents. Best Prac Research Clin Obstet Gynecol 15: 491–506CrossRefGoogle Scholar
  24. 24.
    Hazelgrove JF, Price C, Pappachan J, Smith GB (2001) Multicenter study of obstetric admissions to 14 intensive care units in southern England. Crit Care Med 29: 770–775PubMedCrossRefGoogle Scholar
  25. 25.
    Platteau P, Engelhardt T, Moodley J. Muckart DJJ (1997) Obstetric and gynaecological patients in an intensive care unit: a lyear review. Tropical Doctor 27: 202–206PubMedGoogle Scholar
  26. 26.
    El-Sohl AA, Grant BJB (1996) A comparison of severity of illness scoring systems for critically ill obstetric patients. Chest 110: 1299–1304CrossRefGoogle Scholar
  27. 27.
    Mabie WC, Sibai BM (1990) Treatment in an obstetric intensive care unit. Am J Obstet Gynecol 162: 1–4PubMedGoogle Scholar
  28. 28.
    Johanson R, Anthony J, Domisse J (1995) Obstetric intensive care at Groote Schuur Hospital, Cape Town. J Obstet Gynecol 15: 174–177CrossRefGoogle Scholar
  29. 29.
    Heinonen S, Tyrväinen E, Saarikoski S, Ruokonen R (2002) Need for maternal critical care in obstetrics: a population-based analysis. Int J Obstet Anesth 11:260–264PubMedCrossRefGoogle Scholar
  30. 30.
    Lewinsohn G, Herman A, Leonov Y, Klinowski E (1994) Critically ill obstetrical patients: Outcome and predictability. Crit Care Med 22: 1412–1414PubMedCrossRefGoogle Scholar
  31. 31.
    Lapinsky SE, Kruczynski K, Seaward GR et al (1997) Critical care management of the obstetric patient. Can J Anesth 44 (3): 325–329PubMedCrossRefGoogle Scholar
  32. 32.
    Harris CM, Foley M (2002) Critical care obstetrics: 13 years of experience in a community practice setting. Obstet Gynecol 99 Suppl 1: S79Google Scholar
  33. 33.
    Kilpatrick SJ, Matthay MA (1992) Obstetric patients requiring critical care. Chest 101: 1407–1412PubMedCrossRefGoogle Scholar
  34. 34.
    Cohen J, Singer P, Kogan A et al (2000) Course and outcome of obstetric patients in a general intensive care unit. Acta Obstet Gynecol Scand 79: 846–850PubMedGoogle Scholar
  35. 35.
    Taylor R, Richards GA (2000) Critically ill obstetric and gynaecology patients in the intensive care unit. S Afr Med J 90: 1140–1144PubMedGoogle Scholar
  36. 36.
    Umo-Etuk JI, Lumley J, Holdcroft A (1996) Critically ill parturient women and admission to intensive care: a 5 year review. Int J Obstet Anesth 5: 79–84PubMedCrossRefGoogle Scholar
  37. 37.
    Afessa B, Green B, Delke I, Koch K (2001) Systemic inflammatory response syndrome, organ failure and outcome in critically ill obstetric patients treated in an ICU. Chest 120: 1271–1277PubMedCrossRefGoogle Scholar
  38. 38.
    Knaus WA, Zimmerman JE, Wagner DP et al (1981) APACHE —acute physiological and chronic health evaluation: a physiologically based classification system. Crit Care Med 9: 591–597PubMedCrossRefGoogle Scholar
  39. 39.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE 11: a severity of disease classification syndrome. Crit Care Med 13: 818–829PubMedCrossRefGoogle Scholar
  40. 40.
    Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) Definitions for sepsis and organ failure and guidelines for the use the use of innovative therapies in sepsis. Crit Care Med 20: 864–874CrossRefGoogle Scholar
  41. 41.
    Muckart DJJ, Bhagwanjee S (1997) The ACCP/SCCM Consensus Conference definitions of the systemic inflammatory response syndrome (SIRS) and allied disorders in critically injured patients. Crit Care Med 25: 1789–1895PubMedCrossRefGoogle Scholar
  42. 42.
    The Eclampsia Trial Collaborative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the Eclampsia Collaborative Trial. Lancet 345: 1455–1563Google Scholar
  43. 43.
    Young P, Johanson R (2001) Haemodynamic, invasive and echoecardiographic monitoring in the hypertensive patient. Best Prac Res Clin Obstet Gynaecol 15: 605–622CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 2004

Authors and Affiliations

  • F. Paruk
  • S. Bhagwanjee

There are no affiliations available

Personalised recommendations